NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials
Putting Patients First Blog
SEPTEMBER 26, 2024
Disparities in clinical trial participation have been well-documented, with certain populations, particularly racial and ethnic minorities, women, pregnant and lactating people, older adults, and people with disabilities, often underrepresented in clinical research. Clinical Pharmacology & Therapeutics , 97(3) , 263–273.
52 
Let's personalize your content